DUBLIN–(BUSINESS WIRE)–The “GMP Testing Service Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering.
The GMP testing service market is expected to register a CAGR of 6.5% during the forecast period due to the growing pharmaceutical industry and the increasing need for developing novel devices and drugs.
According to the European Federation of Pharmaceutical Industries and Associations, the overall sales of the pharmaceutical industry worldwide were recorded to be approximately USD 852,647 million in 2017.
Companies Mentioned
- Eurofins Scientific
- PPD Inc.
- Microchem Laboratory
- Sartorius AG
- North American Science Associates Inc.
- Laboratory Corporation of America Holdings (Covance Inc.)
- Sotera Health (Nelson Laboratories LLC)
- Almac Group
- Pace Analytical
- Wuxi AppTec
- Intertek Group Plc
- Charles River Laboratories
Key Market Trends
Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Hold a Major Market Share in the GMP Testing Service Market
The novel drug development in the pharmaceutical and biopharmaceutical industry is expected to drive the market growth in this segment. According to the study published by the Journal of Industrial Microbiology & Biotechnology, almost 300 biopharmaceuticals have been patented in the last three decades. The economic output of the biopharmaceutical industry was accounted to be USD 1.3 trillion in 2015, according to the International Trade Administration. This demands more quality and safety management of products, which is expected to increase GMP testing services.
Moreover, according to the US FDA (Food & Drug Administration) list of GMP facilities, there are around 3,652 facilities related to packaging, analytical testing in 36 countries. Approximately 2,515 facilities in the list accounted for API production facilities and finished dosage form facilities. Thus, the pharmaceutical and biopharmaceutical companies segment is expected to positively impact the GMP testing services market growth.
North America is Expected to Hold a Significant Share in the Market and is Expected to do Same in the Forecast Period.
North America is expected to be a dominant region in the GMP testing services market due to the emerging need for developing new drugs and devices. According to the Centre for Disease Control and Prevention, around USD 3.5 trillion of the amount is spent on chronic diseases in the United States. According to the same source, around 859,000 people die due to heart stroke in the United States. The number of increasing drug manufacturing plants is expected to drive the GMP testing services market growth. According to the United States Food & Drug Administration (FDA), the United States had approximately 4,676 manufacturing sites for drugs. Hence, these factors demand developing new drugs and are expected to boost the demand for GMP testing services market growth.
Key Topics Covered:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Pharmaceutical Industry
4.2.2 Increasing Drug and Devices Development
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Porter’s Five Force Analysis
5 MARKET SEGMENTATION
5.1 By Service Type
5.2 By End User
5.3 Geography
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/52p4og
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900